Knopp Biosciences reports data demonstrating restoration of function by KB-3061
Knopp Biosciences reported the results of preclinical experiments demonstrating that KB-3061, the lead molecule in the Company’s ion channels platform, restored the function of Kv7 potassium channels in cells engineered to express gene variants that cause the rare, neonatal disease KCNQ2-EE. September 17, 2019